Ascelia Pharma AB (publ) (STO:ACE)
Sweden
· Delayed Price · Currency is SEK 2.960
-0.065 (-2.15%)
Apr 28, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 383.78 million as of April 28, 2026. Its market cap has increased by 62.66% in one year.
Market Cap
383.78M
Enterprise Value
334.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.96
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 383.78M, a decrease of -31.75%. That is a compound annual growth rate of -5.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 411.10M |
| Intervacc AB | 412.38M |
| Bio-Works Technologies AB | 317.16M |
| Sprint Bioscience AB | 311.27M |
| Oncopeptides AB | 528.10M |
| Mendus AB | 300.61M |
| Xintela AB | 238.57M |
| FluoGuide | 699.75M |